Quest Diagnostics announced that CEO Jim Davis will present the company's strategy, performance, and insights on market trends at the Baird 2026 Global Healthcare Conference in New York on September 15, 2026. The session will include a fireside chat and Q&A, streamed live and archived on the company's investor relations website. This event provides investors and stakeholders a chance to hear directly from leadership about Quest's role in advancing healthcare diagnostics and future outlook. The webcast will remain available until October 13, 2026.
Humanity Health Inc. and Quest Diagnostics have launched the Humanity Biological Age test in the U.S. through Quest's consumer platform questhealth.com. For $29, individuals can add this test to select health profiles without extra blood draws, recei...
Digi Power X Inc insiders, including President Amar Alec and CEO Michel Amar, purchased shares in recent open-market transactions. Alec bought 10,000 shares at an average price of $3.86, while Amar acquired 20,000 shares at $3.60 each. These purchase...
Quest Diagnostics announced that Sam Samad, the company's Executive Vice President and CFO, will present on the company's strategy, performance, and market trends at the Morgan Stanley 24th Annual Global Healthcare Conference in New York on September...
Quest Diagnostics announced two advancements in its Quest AD-Detect® blood tests for Alzheimer's disease. The company will add the FDA-cleared Elecsys® pTau217 test, the first single-assay blood test for amyloid pathology, to its portfolio by late 20...
